Jose-Carlos Gutiérrez-Ramos
Directeur Technique/Scientifique/R&D chez DANAHER CORPORATION
Fortune : 4 M $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 ans |
Matthew McGrew | M | 52 | - | |
Rainer Blair | M | 60 | 14 ans | |
Steven Rales | M | 72 | 41 ans | |
Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 ans |
Noubar Afeyan | M | 60 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | 6 ans |
Richard Shea | M | 72 | 21 ans | |
Kevin Lee | M | 55 | 12 ans | |
Santiago Arroyo | M | 64 | 7 ans | |
Mitchell Rales | M | 67 | 41 ans | |
Alistair Milnes | M | 50 | 3 ans | |
Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 ans |
Michael Skynner | M | 55 | 11 ans | |
Michael Thomas Ropacki | M | - | 5 ans | |
Jessica Mega | M | 49 | 5 ans | |
Christopher Bouda | M | 47 | 8 ans | |
Thomas J. Adam | M | - | 7 ans | |
Stephen Sands | M | 67 | - | |
A. Sanders | M | 61 | 3 ans | |
Brian Ellis | M | 58 | 8 ans | |
Travis Thompson | M | - | 6 ans | |
Alan Spoon | M | 72 | 25 ans | |
Gregory Winter | M | 73 | 15 ans | |
Teri List-Stoll | F | 61 | 13 ans | |
Raymond Stevens | M | 60 | 7 ans | |
Shantanu Narayen | M | 60 | 11 ans | |
Thomas Freyman | M | 69 | 4 ans | |
Linda Filler | F | 64 | 20 ans | |
Helen Hobbs | M | 71 | 13 ans | |
Jim Smith | M | 64 | 10 ans | |
Janice Bourque | F | 67 | 5 ans | |
Richard Kender | M | 68 | 5 ans | |
Feroz Dewan | M | 47 | 2 ans | |
Elias Zerhouni | M | 72 | 15 ans | |
Peter Barrett | M | 71 | 7 ans | |
John Schwieters | M | 84 | 21 ans | |
Jonathan Bryant | M | - | 4 ans | |
Caroline Kurtz | M | - | 8 ans | |
Alex de Winter | M | - | 4 ans | |
Steve Danehy | M | - | 12 ans | |
Georgeann Couchara | F | 48 | 20 ans | |
Susan Hohenleitner | F | - | 4 ans | |
Travis Taylor | M | - | 3 ans | |
A. JOSEPH ALEX | M | - | - | |
Duane van Arsdale | M | - | 4 ans | |
Agnieszka Cieplinska | F | - | 5 ans | |
Carrie Strom | F | - | 4 ans | |
Zafar Qadir | M | - | 4 ans | |
John Bedford | M | - | 3 ans | |
Nigel Crockett | M | 59 | 5 ans | |
James Sutcliffe | M | 68 | 1 ans | |
Nicholas Keen | M | 56 | 7 ans | |
Pardis Sabeti | M | 48 | 5 ans | |
Pascal Touchon | M | 61 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Sadik Kassim | M | - | 3 ans | |
Pierre Legault | M | 63 | 5 ans | |
William King | M | 56 | 26 ans | |
James F. O'Reilly | M | - | - | |
David Berry | M | 47 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Elizabeth Gordon | M | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
Jennifer Perry | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 ans | |
Craig Wheeler | M | 63 | 14 ans | |
William Steere | M | 87 | 28 ans | |
Simba Gill | M | 60 | 8 ans | |
Michelle Robertson | F | 57 | 3 ans | |
Ann Thorell | F | 56 | 1 ans | |
Todd Shegog | M | 59 | 3 ans | |
Bruce Downey | M | 76 | 11 ans | |
Lee Kalowski | M | 43 | 6 ans | |
Alejandra Carvajal | F | 50 | 4 ans | |
Alison D. Silva | F | 46 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 ans |
Louis J. Arcudi | M | 63 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 7 ans |
Lord Darzi | M | 63 | 5 ans | |
Ankit Mahadevia | M | 43 | 3 ans | |
Amy Schulman | F | 63 | 6 ans | |
David Epstein | M | 62 | 6 ans | |
Ganesh Venkataraman Kaundinya | M | 57 | 17 ans | |
David Perry | M | 56 | 6 ans | |
John Cox | M | 61 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | 3 ans |
Maiken Keson-Brookes | F | 52 | - | |
John Hohneker | M | 64 | 2 ans | |
Luca Scavo | M | 57 | 1 ans | |
Marc Tessier-Lavigne | M | 64 | 4 ans | |
Paul W. May | M | - |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | - |
Elizabeth Stoner | M | 73 | 13 ans | |
Robert Landry | M | 60 | 4 ans | |
Thomas Paul Koestler | M | 71 | 9 ans | |
Ronald O. Robison | M | - | - | |
Theo Melas-Kyriazi | M | 64 | 6 ans | |
Olivier Brandicourt | M | 68 | 13 ans | |
Bruce A. Leicher | M | 68 | 10 ans | |
James Sulat | M | 73 | 11 ans | |
Dana George Mead | M | 88 | 12 ans | |
M. Anthony Burns | M | 81 | 25 ans | |
Walter Lohr | M | 80 | 41 ans | |
Robert N. Burt | M | 86 | 11 ans | |
Marsha Fanucci | F | 70 | 11 ans | |
Georges Gemayel | M | 64 | 4 ans | |
Scott Cundy | M | - | 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 86 | 86,00% |
Royaume-Uni | 16 | 16,00% |
Espagne | 1 | 1,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Jose-Carlos Gutiérrez-Ramos
- Réseau Personnel